Related Experiment Video
Updated: Feb 14, 2026

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue
Published on: July 28, 2023
Human adipose-derived stem cells inhibit bioactivity of keloid fibroblasts
Xiuxia Wang1, Yan Ma2, Zhen Gao3
1Department of Plastic and Reconstructive Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhi Zao Ju Road, Shanghai, 200011, China.
Background:
A keloid is a fibroproliferative disorder occurring in wounds characterized by an exaggerated response to injury. To date, no effective cure has been identified. As multipotent stem cells, human adipose-derived stem cells (ADSCs) may show the possibility for curing diseases such as fibrosis. This study sought to explore the potential role of human ADSCs in curing keloids.
Methods:
After culture in conditioned medium, gene and protein expression of keloid fibroblasts was examined using real-time polymerase chain reaction (RT-PCR) and Western blotting, while analysis of the cell cycle was used to measure the proliferative properties of the cells. Furthermore, ex vivo explant cultures were used to test the effects of ADSC-conditioned medium (ADSC-CM) on CD31+ and CD34+ expression in keloid tissue.
Results:
Our experimental results show that ADSC-CM was able to attenuate extracellular matrix-related gene expression as well as decrease protein expression. Cell proliferation was significantly suppressed in our study. CD31+ and CD34+ vessels in ex vivo explants were reduced by 55% and 57% in treatment groups compared with control groups.
Conclusions:
Human ADSC-CM significantly inhibited keloid fibroblast-related bioactivities.
Insights
Human adipose-derived stem cells (ADSCs) show promise in treating keloids. ADSC-conditioned medium significantly reduced keloid fibroblast activity and suppressed cell proliferation, suggesting a potential new therapy for this fibrotic disorder.
Area of Science:
- Regenerative Medicine
- Fibrosis Research
- Stem Cell Therapy
Background:
- Keloids are fibroproliferative disorders resulting from an exaggerated wound healing response.
- Current treatments for keloids lack definitive efficacy.
- Human adipose-derived stem cells (ADSCs) offer potential therapeutic benefits for fibrotic conditions.
Purpose of the Study:
- To investigate the potential of human ADSCs in treating keloids.
- To evaluate the effects of ADSC-conditioned medium (ADSC-CM) on keloid fibroblast bioactivity.
Main Methods:
- Keloid fibroblasts were cultured in ADSC-CM.
- Gene and protein expression, cell cycle, and proliferation were analyzed using RT-PCR and Western blotting.
- Ex vivo keloid explants were used to assess the impact of ADSC-CM on CD31+ and CD34+ vessel expression.
Main Results:
- ADSC-CM significantly attenuated extracellular matrix-related gene and protein expression in keloid fibroblasts.
- Cell proliferation of keloid fibroblasts was markedly suppressed.
- A significant reduction in CD31+ (55%) and CD34+ (57%) vessels was observed in ex vivo keloid explants treated with ADSC-CM.
Conclusions:
- Human ADSC-CM demonstrated significant inhibitory effects on keloid fibroblast bioactivities.
- ADSC-CM presents a promising therapeutic avenue for managing keloid formation and progression.
Related Concept Videos
Induced Pluripotent Stem Cells
Feedback Inhibition
Adult Stem Cells
Embryonic Stem Cells
Bioactivation and Tissue Toxicity
Introduction to Fibroblasts

